Amanda Berger and Bridgette Tippin Davis look ahead at the refinements and advances coming to genetic testing for epilepsy.
-
Healthcare Providers
-
Frequently Ordered Tests
+RNAinsight® Now Available: Identify more patients with hereditary cancer. Provide more accurate results. Learn more.Frequently Ordered Tests
Choose a Disease Type
Use AmbryPort
Visit our secure online portal to start your order.
AmbryPort Login or Create an AccountAdditional Information
Delivering Accuracy
Confidently guiding patient care through reliable results
- Test Development
- Quality Control
- Confirmatory Testing
Bringing Clarity
Finding answers through superior variant interpretation
- Variant Assessment
- Ambry’s Translational Genomics (ATG) Lab
- Family Studies Program
Advancing Science
Understanding human disease through innovation, research, and partnerships
- History of Innovation
- Practice-Changing Research
- Precision Medicine
Select a Form Type
Excellent Coverage, Personalized Support
Preverification
Will insurance cover my patient's genetic test?
Click HerePayor Relations
Why partner with us?
Learn MoreWelcome
Please select a menu option
![New Telemedicine Resources]()
![Introducing +RNAinsight]()
![EducateNext]()
-
- Patients
-
Advancing Science
-
About
-
We are driven to give healthcare providers the most advanced testing information available so you can determine the best treatment options for your patients.
-
- COVID Response
Ambry Shares: What’s Next in Epilepsy Genetic Testing
Senior Product Manager, Neurology Ambry Genetics
Laboratory Technical Director Ambry Genetics
- Date: Tue, November 17, 2015
- Time: 10:00am PST
- Duration: 1 hour and 15 minutes
- C.E.U. --
- P.A.C.E. --
Webinar Newsletter
Subscribe to receive notifications for future webinars.
Subscribe